Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

Tietoevry Q2'23: Attraktiv värdering, marknadsosäkerhet på kort sikt

Tietoevry

Tietoevrys Q2 var svagare än vi förväntade oss men stark orderingång och effektiveringsåtgärder stöder H2. På videon berättar analytiker Joni Grönqvist om Tietoevrys situation och framtidsutsikter.

Läs den senaste analysen, publicerad 2023-07-24: https://www.inderes.se/research/tietoevry-uncertainty-limits-enthusiasm-about-the-share

Innehåll:
00:00 Start
00:18 Tietoevry Q2’23
01:19 Tillväxt- och lönsamhetsmålen
02:30 Segmenten
04:16 Åren 2023 och 2024
05:42 Värderingen

Stay up to date
Analyst Interviews

Recent videos

Orion as an Investment | Life Science Night Dec. 9, 2025
13.12.2025, 12.50 Orion
AKTIER MED FRIIS - UGE 50 2025
12.12.2025, 12.00
HCA Morgenbørs 12/12 - Positive futures og fokus på FLSmidth og fedme aktier
12.12.2025, 09.27 Novo Nordisk
A sit-down with CEO Remco Westermann
12.12.2025, 09.09 Verve Group
Aiforia as an Investment | Life Science Night Dec 9, 2025
11.12.2025, 11.00 Aiforia Technologies
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.